Immunotherapy impact factor 2020
WitrynaCancer Immunology, Immunotherapy is a monthly peer-reviewed medical journal published by Springer Science+Business Media. According to the Journal Citation … Witryna13 kwi 2024 · The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy and, in doing so, aims to enrich communication and advance …
Immunotherapy impact factor 2020
Did you know?
Witryna4 kwi 2024 · Impact Factor (JCR):12.485. IF rank (Oncology):25/245. IF rank ... Tatiana A.; Shilyagina, Natalia Y.; et al 10.1136/jitc-2024-002038 Radiation dose and fraction in immunotherapy ... Yiying; et al 10.1136/jitc-2024-001136 Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer … Witrynav.2 (Suppl 3) 2014. Vol. 1. 2013. v.1. 2013. v.1 (Suppl 1) 2013. Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group.
WitrynaAims and scope. Since its inception in 1976, Cancer Immunology, Immunotherapy (CII) has reported significant advances in the field of tumor immunology. The journal serves as a forum for new concepts and advances in basic, translational, and clinical cancer immunology and immunotherapy. CII is keen to publish broad-ranging ideas … WitrynaRecent advances in immunotherapies against infectious diseases. Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity. Behind the scenes …
WitrynaJournal Announcements. JITC's latest Impact Factor of 12.485 was announced in the 2024 Journal Citation Reports (JCR), placing the journal in the top 12% of the … WitrynaInternational Scientific Journal & Country Ranking. Only Open Access Journals Only SciELO Journals Only WoS Journals
Witryna3 lut 2024 · Therapeutic Advances in Vaccines and Immunotherapy (TAV) is a peer-reviewed open access journal which focuses on advances in the fields of vaccinology …
Witryna15 gru 2024 · Volume 12, 2024 Vol 11, 2024 Vol 10, 2024 Vol 9, 2024 Vol 8, 2024 Vol 7, 2024 Vol 6, 2024 Vol 5, 2016 Vol 4, 2015 Vol 3, 2014 ... Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic ... Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non … theory sleeveless navy knit topWitrynaHPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US. Kunal Saxena, Niranjan Kathe, Poorva Sardana, Lixia Yao, Ya-Ting Chen & Noel T. Brewer. Article: 2161253. Published online: 11 Jan 2024. 1088 Views. theory sleeveless peplum topWitrynaLiczba wierszy: 70 · Scope. Journal of Immunotherapy features rapid publication of articles on immunomodulators, lymphokines, antibodies, cells, and cell products in … shs heatingWitrynaScope. The Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed, online journal of the Society for Immunotherapy of Cancer (SITC). The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy and, in doing so, aims to enrich communication and advance scientific understanding … theory sleeveless leather top 6WitrynaJournal of Immunotherapy features rapid publication of articles on immunomodulators, lymphokines, antibodies, cells, and cell products in cancer biology and therapy. … shs health techWitrynaImmunotherapy Impact Factor by Web of Science. Index. SCIE/SSCI Impact Factor. 4.196 by WOS ... 2024 Impact Factor . 3.05 3.114 3.231. 2024 Impact Factor . 2.551 2.7 2.683. 2024 Impact Factor . 2.615 2.678 2.588. ... Impact Factor. Impact factor (IF) is a scientometric factor based on the yearly average number of citations on articles … shs health solutionsWitryna3 lut 2024 · Therapeutic Advances in Vaccines and Immunotherapy (TAV) is a peer-reviewed open access journal which focuses on advances in the fields of vaccinology and immunotherapy, reporting on both prophylactic and therapeutic vaccination as well as an ever-growing repertoire of other immunotherapeutic interventions. The journal is a … shs health plans